175 related articles for article (PubMed ID: 14500385)
1. Role of MutSalpha in the recognition of iododeoxyuridine in DNA.
Berry SE; Loh T; Yan T; Kinsella TJ
Cancer Res; 2003 Sep; 63(17):5490-5. PubMed ID: 14500385
[TBL] [Abstract][Full Text] [Related]
2. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
3. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells.
Berry SE; Garces C; Hwang HS; Kunugi K; Meyers M; Davis TW; Boothman DA; Kinsella TJ
Cancer Res; 1999 Apr; 59(8):1840-5. PubMed ID: 10213489
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
[TBL] [Abstract][Full Text] [Related]
5. Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX.
Mac Partlin M; Homer E; Robinson H; McCormick CJ; Crouch DH; Durant ST; Matheson EC; Hall AG; Gillespie DA; Brown R
Oncogene; 2003 Feb; 22(6):819-25. PubMed ID: 12584560
[TBL] [Abstract][Full Text] [Related]
6. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents.
Christmann M; Kaina B
J Biol Chem; 2000 Nov; 275(46):36256-62. PubMed ID: 10954713
[TBL] [Abstract][Full Text] [Related]
7. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
[TBL] [Abstract][Full Text] [Related]
8. Efficient repair of A/C mismatches in mouse cells deficient in long-patch mismatch repair.
Oda S; Humbert O; Fiumicino S; Bignami M; Karran P
EMBO J; 2000 Apr; 19(7):1711-8. PubMed ID: 10747038
[TBL] [Abstract][Full Text] [Related]
9. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatch-binding activity.
Christmann M; Tomicic MT; Kaina B
Nucleic Acids Res; 2002 May; 30(9):1959-66. PubMed ID: 11972333
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
[TBL] [Abstract][Full Text] [Related]
12. Targeting DNA mismatch repair for radiosensitization.
Berry SE; Kinsella TJ
Semin Radiat Oncol; 2001 Oct; 11(4):300-15. PubMed ID: 11677655
[TBL] [Abstract][Full Text] [Related]
13. Mlh1 can function in antibody class switch recombination independently of Msh2.
Schrader CE; Vardo J; Stavnezer J
J Exp Med; 2003 May; 197(10):1377-83. PubMed ID: 12743174
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
15. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system.
Wu J; Zhu BB; Yu J; Zhu H; Qiu L; Kindy MS; Gu L; Seidel A; Li GM
Nucleic Acids Res; 2003 Nov; 31(22):6428-34. PubMed ID: 14602900
[TBL] [Abstract][Full Text] [Related]
17. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
[TBL] [Abstract][Full Text] [Related]
18. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
19. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
20. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
